Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Pellicane · SciRah

Researcher profile · Semantic Scholar

J. Pellicane

Share profile

J. Pellicane — researcher profile on SciRah

h-index: 15
Works: 41
Citations: 846

Most-cited papers

Meckel's diverticulum: a ten-year experience.
J. F. Arnold, J. Pellicane
1997The American surgeon110 citations
Semantic Scholar
Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
P. Whitworth, L. Stork-Sloots, F. de Snoo, P. Richards +10 more
2014Annals of Surgical Oncology100 citations Open access
Semantic Scholar
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
P. Whitworth, P. Beitsch, A. Mislowsky, J. Pellicane +9 more
2016Annals of Surgical Oncology78 citations Open access
Semantic Scholar
Preventable complications and death from multiple organ failure among geriatric trauma victims.
J. Pellicane, Karl Byrne, Eric J. Demaria
1992Journal of Trauma75 citations
Semantic Scholar
The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice.
David A. Bettinger, J. Pellicane, Wallace C. Tarry, Dome R. Yager +4 more
1993Journal of Trauma69 citations
Semantic Scholar
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy
S. Weinmann, M. Leo, Melanie Francisco, Charisma L. Jenkins +8 more
2020Clinical Cancer Research59 citations
Semantic Scholar
The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
C. Shah, T. Bremer, C. Cox, P. Whitworth +19 more
2021Annals of Surgical Oncology46 citations Open access
Semantic Scholar
Twelve-Month Follow-Up Results of a Trial Utilizing Axxent Electronic Brachytherapy to Deliver Intraoperative Radiation Therapy for Early-Stage Breast Cancer
O. Ivanov, A. Dickler, Bennett Y. F. Lum, J. Pellicane +1 more
2011Annals of Surgical Oncology39 citations
Semantic Scholar
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
P. Beitsch, P. Whitworth, P. Baron, Michael Rotkis +10 more
2017Annals of Surgical Oncology38 citations
Semantic Scholar
Surgical Delay of the Nipple–Areolar Complex in High-risk Nipple-sparing Mastectomy Reconstruction
Maryann E. Martinovic, J. Pellicane, N. Blanchet
2016Plastic and Reconstructive Surgery, Global Open32 citations Open access
Semantic Scholar
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
P. Baron, P. Beitsch, Danielle Boselli, J. Symanowski +12 more
2015Annals of Surgical Oncology32 citations Open access
Semantic Scholar
Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor.
E. DeMaria, J. Pellicane, Ronzo B. Lee
1992Journal of Trauma32 citations
Semantic Scholar
Interleukin-1 receptor antagonist improves survival and preserves organ adenosine-5'-triphosphate after hemorrhagic shock.
J. Pellicane, E. DeMaria, A. Abd-elfattah, H. Reines +2 more
1993Surgery27 citations
Semantic Scholar
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
Chirag Shah, P. Whitworth, F. Vicini, S. Narod +35 more
2024Annals of Surgical Oncology18 citations Open access
Semantic Scholar
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
P. Whitworth, P. Beitsch, J. Pellicane, P. Baron +21 more
2022JCO Precision Oncology15 citations Open access
Semantic Scholar
Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures
P. Beitsch, P. Whitworth, P. Baron, J. Pellicane +4 more
2016Annals of Surgical Oncology14 citations
Semantic Scholar
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
P. Whitworth, P. Beitsch, J. Pellicane, P. Baron +23 more
2022Annals of Surgical Oncology11 citations Open access
Semantic Scholar
MammaPrint Index as a predictive biomarker for neoadjuvant chemotherapy response and outcome in patients with HR+HER2- breast cancer in NBRST.
P. Beitsch, J. Pellicane, L. Pusztai, P. Baron +13 more
2023Journal of Clinical Oncology10 citations Open access
Semantic Scholar
A novel ultrasound-guided electrosurgical loop device for intra-operative excision of breast lesions; an improvement in surgical technique.
R. Fine, M. Schwalke, J. Pellicane, D. Attai
2009American Journal of Surgery7 citations
Semantic Scholar
Nonocclusive intestinal ischemia: improved outcome with early diagnosis and therapy.
D. Bryant, J. Pellicane, R. Davies
1997The American surgeon7 citations
Semantic Scholar
Decreased lactate in endotoxin-resistant mice undergoing hemorrhage is independent of tumor necrosis factor availability.
J. Pellicane, Dennis C. Gore, Eric J. DeMaria
1994Journal of Surgical Research6 citations
Semantic Scholar
Correction to: The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
C. Shah, T. Bremer, C. Cox, P. Whitworth +19 more
2021Annals of Surgical Oncology5 citations Open access
Semantic Scholar
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
P. Whitworth, P. Beitsch, M. Murray, P. Richards +19 more
2022JCO Precision Oncology4 citations Open access
Semantic Scholar
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
J. Pellicane, P. Beitsch, D. Rock, R. Budway +19 more
2022Surgical oncology4 citations Open access
Semantic Scholar
Abstract PD9-01: 5-year outcomes in the NBRST trial: Preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival
P. Whitworth, J. Pellicane, P. Baron, P. Beitsch +15 more
2021Poster Spotlight Session Abstracts3 citations
Semantic Scholar
Abstract S5-01: DCIS biological risk profile predicts risk of recurrence after breast conserving surgery in a Kaiser Permanente NW population
T. Bremer, P. Whitworth, M. Leo, T. Barry +8 more
20171 citations
Semantic Scholar
Functional subtyping with BluePrint 80-gene profile to identify distinct triple-positive subtypes with and without trastuzumab/chemosensitivity.
P. Whitworth, P. Beitsch, Michael Rotkis, J. Pellicane +13 more
2015Journal of Clinical Oncology1 citations
Semantic Scholar
Genomic Testing for Breast Cancer
J. Pellicane
20131 citations
Semantic Scholar
Abstract PS5-04-19: 70-gene signature high risk classification provides stronger prognostic value than histologic grade in hr+ her2- early breast cancer
E. Cobain, L. Pusztai, C. Graham, P. Beitsch +21 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Abstract P1-11-24: Neoadjuvant Chemotherapy for T3 tumors in the Era of Precision Medicine - Biology is Still King
R. Rahman, L. Lee, Alfredo A. Santillan, M. Habibi +9 more
2025Clinical Cancer Research0 citations
Semantic Scholar
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
C. Shah, P. Whitworth, F. Vicini, S. Narod +35 more
2024Annals of Surgical Oncology0 citations Open access
Semantic Scholar
ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
P. Whitworth, P. Beitsch, J. Pellicane, P. Baron +23 more
2022Annals of Surgical Oncology0 citations Open access
Semantic Scholar
Abstract PS4-04: Molecular subtyping by BluePrint improves prediction of treatment responses and survival outcomes in patients with discordant clinical and genomic classification
P. Whitworth, J. Pellicane, P. Baron, P. Beitsch +15 more
2021Poster Session Abstracts0 citations
Semantic Scholar
Abstract P4-14-10: Pertuzumab overcomes chemotherapy/trastuzumab resistance in ER+/Her2+ tumors classified as luminal functional subtype by the 80-gene BluePrint assay in the prospective neo-adjuvant breast registry symphony trial (NBRST)
B. Peter, W. Pat, B. Paul, B. Jennifer +13 more
20160 citations
Semantic Scholar
Abstract P4-14-29: One-third of HER2 positive patients have 80-gene luminal subtype that is resistant to chemo-trastuzumab but sensitive to chemo-trastuzumab-pertuzumab: Critical implications for the adjuvant setting from the NBRST phase 4 neoadjuvant study:
P. Beitsch, P. Whitworth, P. Baron, J. Beatty +13 more
20160 citations
Semantic Scholar
Abstract P1-14-05: Three distinct HER2 subtypes identified by BluePrint 80-gene functional subtyping predict treatment-specific response in the prospective neo-adjuvant NBRST registry
P. Whitworth, P. Beitsch, P. Baron, J. Beatty +13 more
20160 citations
Semantic Scholar
Abstract P3-07-67: Chemosensitivity and endocrine sensitivity predicted by MammaPrint and BluePrint in clinical luminal patients in the prospective NBRST study
J. Pellicane, P. Whitworth, P. Beitsch, P. Baron +13 more
20160 citations
Semantic Scholar
How Molecular Subtyping is Changing
J. Pellicane
20150 citations
Semantic Scholar
Abstract P6-08-22: Functional subtyping with BluePrint 80-gene profile identifies two distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity: Implications for treatment from the NBRST registry
P. Whitworth, J. Beatty, P. Baron, P. Richards +11 more
20150 citations
Semantic Scholar
Determining whether functional subtyping with BluePrint 80-gene profile could potentially identify two distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity.
P. Whitworth, P. Beitsch, Michael C. Rotkis, J. Pellicane +13 more
20150 citations
Semantic Scholar
Resolution of Breast Edema over the Course of MammoSite Partial Breast Radiation Treatment Can Cause Decreased Skin Sparing
B. K. Rice, T. Torre, John E. Walker, N. Sakthi +1 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Beitsch×21
Invite
P. Beitsch — researcher profile on SciRah
P. Whitworth×19
Invite
P. Whitworth — researcher profile on SciRah
P. Baron×18
Invite
P. Baron — researcher profile on SciRah
A. Mislowsky×16
Invite
A. Mislowsky — researcher profile on SciRah

×15

Invite

P. Richards — researcher profile on SciRah

Invite

L. Lee — researcher profile on SciRah

Invite

C. Nash — researcher profile on SciRah

M. Gittleman×15

Invite

M. Gittleman — researcher profile on SciRah

Invite

C. Dul — researcher profile on SciRah

Invite

F. de Snoo — researcher profile on SciRah

Stephanie Akbari×11

Invite

Stephanie Akbari — researcher profile on SciRah

Mary E. Murray×11

Invite

Mary E. Murray — researcher profile on SciRah